drugset / Trial / NCT02393937

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

NCT02393937

Phase 3 Completed 963 enrolled bioRASI, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

Timeline

Start
2015-02
Primary completion
2015-07
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 1 % Topical

Indications